ICU Medical, Inc. Forecast, price target & analysts
ICU Medical, Inc. Target price 2025 - Analyst rating & recommendation
ICU Medical, Inc. Classifications & Recommendation:
ICU Medical, Inc. Price Target
| Target Price | $209.75 |
| Price | $149.75 |
| Potential |
40.07%
register free of charge
|
| Number of Estimates | 4 |
|
4 Analysts have issued a price target ICU Medical, Inc. 2026 .
The average ICU Medical, Inc. target price is $209.75.
This is
40.07%
register free of charge
$225.00
50.25%
register free of charge
$200.00
33.56%
register free of charge
|
|
| A rating was issued by 6 analysts: 4 Analysts recommend ICU Medical, Inc. to buy, 2 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the ICU Medical, Inc. stock has an average upside potential 2026 of
40.07%
register free of charge
|
Sales and Margin forecast 2024, 2025 & 2026
| Dec '23 |
2024 Estimates |
|
|---|---|---|
| Revenue Billion $ | 2.26 | 2.32 |
| 0.76% | 2.63% | |
| EBITDA Margin | 12.85% | 15.55% |
| 20.09% | 20.97% | |
| Net Margin | -1.33% | -4.84% |
| 60.15% | 263.39% |
5 Analysts have issued a sales forecast ICU Medical, Inc. 2024 . The average ICU Medical, Inc. sales estimate is
This results in the following potential growth metrics:
5 Analysts have issued an ICU Medical, Inc. EBITDA forecast 2024. The average ICU Medical, Inc. EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
4 ICU Medical, Inc. Analysts have issued a net profit forecast 2024. The average ICU Medical, Inc. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 & 2026
| Dec '23 |
2024 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -1.23 | -4.59 |
| 60.45% | 273.17% | |
| P/E | negative | |
| EV/Sales | 2.21 |
4 Analysts have issued a ICU Medical, Inc. forecast for earnings per share. The average ICU Medical, Inc. <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Based on analysts' sales estimates for 2024, the ICU Medical, Inc. stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
ICU Medical, Inc....
Current ICU Medical, Inc. Upgrades & Downgrades Beta
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Jefferies | Locked ➜ Locked | Locked | Dec 11 2024 |
| Keybanc | Locked ➜ Locked | Locked | Nov 13 2024 |
| Needham | Locked ➜ Locked | Locked | Nov 13 2024 |
| Keybanc | Locked ➜ Locked | Locked | Oct 15 2024 |
| Jefferies | Locked ➜ Locked | Locked | Oct 14 2024 |
| Needham | Locked ➜ Locked | Locked | Oct 10 2024 |
| Raymond James | Locked ➜ Locked | Locked | Sep 12 2024 |
| Analyst Rating | Date |
|---|---|
|
Locked
Jefferies: Locked ➜ Locked
|
Dec 11 2024 |
|
Locked
Keybanc: Locked ➜ Locked
|
Nov 13 2024 |
|
Locked
Needham: Locked ➜ Locked
|
Nov 13 2024 |
|
Locked
Keybanc: Locked ➜ Locked
|
Oct 15 2024 |
|
Locked
Jefferies: Locked ➜ Locked
|
Oct 14 2024 |
|
Locked
Needham: Locked ➜ Locked
|
Oct 10 2024 |
|
Locked
Raymond James: Locked ➜ Locked
|
Sep 12 2024 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
